Literature DB >> 9216462

Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.

M Kaplan1, C Leiter, C Hammerman, B Rudensky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9216462

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Assessment of G6PD screening program in premature infants in a NICU.

Authors:  R Lam; H Li; M L Nock
Journal:  J Perinatol       Date:  2015-10-22       Impact factor: 2.521

2.  Effect of vitamin K1 on glucose-6-phosphate dehydrogenase deficient neonatal erythrocytes in vitro.

Authors:  M Kaplan; D Waisman; D Mazor; C Hammerman; D Bader; A Abrahamov; N Meyerstein
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

3.  High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia.

Authors:  Josko Markić; Vjekoslav Krzelj; Anita Markotić; Eugenija Marusić; Luka Stricević; Jaksa Zanchi; Nada Bosnjak; Ada Sapunar
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

Review 4.  Erythrocyte disorders in the perinatal period.

Authors:  Laurie A Steiner; Patrick G Gallagher
Journal:  Semin Perinatol       Date:  2007-08       Impact factor: 3.300

5.  The reality of using primaquine.

Authors:  Kathy L Burgoine; Germana Bancone; François Nosten
Journal:  Malar J       Date:  2010-12-27       Impact factor: 2.979

6.  Lower reference limits of quantitative cord glucose-6-phosphate dehydrogenase estimated from healthy term neonates according to the Clinical and Laboratory Standards Institute guidelines: a cross sectional retrospective study.

Authors:  Sameer Yaseen Al-Abdi; Amina Suleman Alsaigh; Fahima Lugman Aldawoud; Amal Ali Al Sadiq
Journal:  BMC Pediatr       Date:  2013-09-10       Impact factor: 2.125
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.